Plain-English translation of NCT06199856 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This trial is developing an artificial intelligence (AI) system that uses ultrasound imaging to detect muscle loss earlier and more easily. Researchers want to create a tool that can quickly identify who is at risk of sarcopenia — a condition where older adults lose muscle mass and strength — so that people can get help before serious problems develop.
Right now, detecting muscle loss requires multiple tests including X-rays, strength testing, and walking assessments. This new AI-powered ultrasound tool could make screening simpler, faster, and more accessible, especially for older adults who may also have cancer, diabetes, kidney disease, or other conditions that speed up muscle loss.
You likely qualify if…
You likely don't qualify if…
You will have ultrasound imaging done of your muscles, similar to the ultrasound scans used during pregnancy — it's painless and non-invasive. Researchers may also perform standard tests like grip strength measurement and walking assessments. Depending on where you are (in a hospital or in your community), you may have one or more visits to complete these evaluations.
AI-generated summary from trial data · Aug 29, 2026 · Not medical advice
China
Enrollment target
~1,500 participants
Started
October 2020
Primary completion
December 2027
Last updated on clinicaltrials.gov in March 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Xinyi Tang, Dr.
Department of Medical Ultrasound, West China Hospital, Sichuan University
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.